175 related articles for article (PubMed ID: 2448307)
1. Interaction of tetrandrine with slowly inactivating calcium channels. Characterization of calcium channel modulation by an alkaloid of Chinese medicinal herb origin.
King VF; Garcia ML; Himmel D; Reuben JP; Lam YK; Pan JX; Han GQ; Kaczorowski GJ
J Biol Chem; 1988 Feb; 263(5):2238-44. PubMed ID: 2448307
[TBL] [Abstract][Full Text] [Related]
2. Bis(benzylisoquinoline) analogs of tetrandrine block L-type calcium channels: evidence for interaction at the diltiazem-binding site.
Felix JP; King VF; Shevell JL; Garcia ML; Kaczorowski GJ; Bick IR; Slaughter RS
Biochemistry; 1992 Dec; 31(47):11793-800. PubMed ID: 1332772
[TBL] [Abstract][Full Text] [Related]
3. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
4. Interactions of DPI 201-106, a novel cardiotonic agent, with cardiac calcium channels.
Siegl PK; Garcia ML; King VF; Scott AL; Morgan G; Kaczorowski GJ
Naunyn Schmiedebergs Arch Pharmacol; 1988 Dec; 338(6):684-91. PubMed ID: 2854216
[TBL] [Abstract][Full Text] [Related]
5. Substituted diphenylbutylpiperidines bind to a unique high affinity site on the L-type calcium channel. Evidence for a fourth site in the cardiac calcium entry blocker receptor complex.
King VF; Garcia ML; Shevell JL; Slaughter RS; Kaczorowski GJ
J Biol Chem; 1989 Apr; 264(10):5633-41. PubMed ID: 2538426
[TBL] [Abstract][Full Text] [Related]
6. Amiloride analogs inhibit L-type calcium channels and display calcium entry blocker activity.
Garcia ML; King VF; Shevell JL; Slaughter RS; Suarez-Kurtz G; Winquist RJ; Kaczorowski GJ
J Biol Chem; 1990 Mar; 265(7):3763-71. PubMed ID: 2154487
[TBL] [Abstract][Full Text] [Related]
7. Tetrandrine inhibits both T and L calcium channel currents in ventricular cells.
Liu QY; Karpinski E; Pang PK
J Cardiovasc Pharmacol; 1992 Oct; 20(4):513-9. PubMed ID: 1280704
[TBL] [Abstract][Full Text] [Related]
8. Tetrandrine: a new ligand to block voltage-dependent Ca2+ and Ca(+)-activated K+ channels.
Wang G; Lemos JR
Life Sci; 1995; 56(5):295-306. PubMed ID: 7837929
[TBL] [Abstract][Full Text] [Related]
9. Tetrandrine and related bis-benzylisoquinoline alkaloids from medicinal herbs: cardiovascular effects and mechanisms of action.
Kwan CY; Achike FI
Acta Pharmacol Sin; 2002 Dec; 23(12):1057-68. PubMed ID: 12466042
[TBL] [Abstract][Full Text] [Related]
10. Blocking T-type calcium channels with tetrandrine inhibits steroidogenesis in bovine adrenal glomerulosa cells.
Rossier MF; Python CP; Capponi AM; Schlegel W; Kwan CY; Vallotton MB
Endocrinology; 1993 Mar; 132(3):1035-43. PubMed ID: 8382595
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the calcium entry blocker receptor complex in cardiac sarcolemmal membrane vesicles.
Kaczorowski GJ; Garcia ML; King VF
Prog Clin Biol Res; 1988; 252():29-34. PubMed ID: 2450371
[No Abstract] [Full Text] [Related]
12. Blockade of voltage-operated calcium channels, increase in spontaneous catecholamine release and elevation of intracellular calcium levels in bovine chromaffin cells by the plant alkaloid tetrandrine.
Bickmeyer U; Weinsberg F; Müller E; Wiegand H
Naunyn Schmiedebergs Arch Pharmacol; 1998 Apr; 357(4):441-5. PubMed ID: 9606031
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of calcium channels from cardiac sarcolemmal membrane vesicles into planar lipid bilayers.
Ehrlich BE; Schen CR; Garcia ML; Kaczorowski GJ
Proc Natl Acad Sci U S A; 1986 Jan; 83(1):193-7. PubMed ID: 2417238
[TBL] [Abstract][Full Text] [Related]
14. Positive heterotropic allosteric regulators of dihydropyridine binding increase the Ca2+ affinity of the L-type Ca2+ channel. Stereoselective reversal by the novel Ca2+ antagonist BM 20.1140.
Staudinger R; Knaus HG; Glossmann H
J Biol Chem; 1991 Jun; 266(17):10787-95. PubMed ID: 1645709
[TBL] [Abstract][Full Text] [Related]
15. Characterization of verapamil binding sites in cardiac membrane vesicles.
Garcia ML; Trumble MJ; Reuben JP; Kaczorowski GJ
J Biol Chem; 1984 Dec; 259(24):15013-6. PubMed ID: 6096353
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of vascular relaxation by thaligrisine: functional and binding assays.
Tur R; Magraner J; Catret M; Elorriaga M; Ivorra MD; D'Ocon P; Bermejo A; Cabedo N; Cortes D; Anselmi E
Life Sci; 2000 Aug; 67(13):1535-48. PubMed ID: 10983849
[TBL] [Abstract][Full Text] [Related]
17. Tetrandrine: a novel calcium channel antagonist inhibits type I calcium channels in neuroblastoma cells.
Liu QY; Karpinski E; Rao MR; Pang PK
Neuropharmacology; 1991 Dec; 30(12A):1325-31. PubMed ID: 1787886
[TBL] [Abstract][Full Text] [Related]
18. Effects of tetrandrine on calcium channel currents of bovine chromaffin cells.
Weinsberg F; Bickmeyer U; Wiegand H
Neuropharmacology; 1994 Jul; 33(7):885-90. PubMed ID: 7969809
[TBL] [Abstract][Full Text] [Related]
19. Dihydropyridine binding and Ca(2+)-channel characterization in clonal calcitonin-secreting cells.
Krautwurst D; Scherübl H; Kleppisch T; Hescheler J; Schultz G
Biochem J; 1993 Feb; 289 ( Pt 3)(Pt 3):659-65. PubMed ID: 8382045
[TBL] [Abstract][Full Text] [Related]
20. Temperature-dependent regulation of d-cis-[3H]diltiazem binding to Ca2+ channels by 1,4-dihydropyridine channel agonists and antagonists.
Glossmann H; Linn T; Rombusch M; Ferry DR
FEBS Lett; 1983 Aug; 160(1-2):226-32. PubMed ID: 6309565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
